Beneficial Ownership of Registrable Securities. (a) Total number of shares of Common Stock to be beneficially owned as December 31, 2023 (including shares of Common Stock that the undersigned has the right to acquire beneficial ownership, as specified in Rule 13d-3(d)(1) under the Exchange Act):
Appears in 1 contract
Beneficial Ownership of Registrable Securities. (a) Total number of shares of Common Stock to be beneficially owned as December 31June 30, 2023 (including shares of Common Stock that the undersigned has the right to acquire beneficial ownership, as specified in Rule 13d-3(d)(1) under the Exchange Act):
Appears in 1 contract
Samples: Registration Rights Agreement (Acelrx Pharmaceuticals Inc)
Beneficial Ownership of Registrable Securities. (a) Total number of shares of Common Stock to be Shares beneficially owned as December 31, 2023 of [DATE] (including shares of Common Stock Shares that the undersigned has the right to acquire beneficial ownershipwithin 60 days, as specified in Rule 13d-3(d)(1) under the Exchange Act of 1934, as amended (the “Exchange Act”)):
Appears in 1 contract
Beneficial Ownership of Registrable Securities. (a) Total number of shares of Common Stock to be beneficially owned as December March 31, 2023 2024 (including shares of Common Stock that the undersigned has the right to acquire beneficial ownership, as specified in Rule 13d-3(d)(1) under the Exchange Act):
Appears in 1 contract
